1. Home
  2. BCRX vs CABO Comparison

BCRX vs CABO Comparison

Compare BCRX & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • CABO
  • Stock Information
  • Founded
  • BCRX 1986
  • CABO 1980
  • Country
  • BCRX United States
  • CABO United States
  • Employees
  • BCRX N/A
  • CABO N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • CABO Cable & Other Pay Television Services
  • Sector
  • BCRX Health Care
  • CABO Telecommunications
  • Exchange
  • BCRX Nasdaq
  • CABO Nasdaq
  • Market Cap
  • BCRX 1.7B
  • CABO 1.4B
  • IPO Year
  • BCRX 1994
  • CABO N/A
  • Fundamental
  • Price
  • BCRX $9.97
  • CABO $165.70
  • Analyst Decision
  • BCRX Buy
  • CABO Hold
  • Analyst Count
  • BCRX 8
  • CABO 3
  • Target Price
  • BCRX $16.75
  • CABO $231.00
  • AVG Volume (30 Days)
  • BCRX 5.9M
  • CABO 212.4K
  • Earning Date
  • BCRX 05-05-2025
  • CABO 05-01-2025
  • Dividend Yield
  • BCRX N/A
  • CABO 7.14%
  • EPS Growth
  • BCRX N/A
  • CABO N/A
  • EPS
  • BCRX N/A
  • CABO N/A
  • Revenue
  • BCRX $503,485,000.00
  • CABO $1,555,831,000.00
  • Revenue This Year
  • BCRX $27.64
  • CABO N/A
  • Revenue Next Year
  • BCRX $13.42
  • CABO N/A
  • P/E Ratio
  • BCRX N/A
  • CABO N/A
  • Revenue Growth
  • BCRX 41.67
  • CABO N/A
  • 52 Week Low
  • BCRX $5.06
  • CABO $150.00
  • 52 Week High
  • BCRX $11.11
  • CABO $437.00
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 65.89
  • CABO 29.15
  • Support Level
  • BCRX $9.83
  • CABO $150.00
  • Resistance Level
  • BCRX $11.11
  • CABO $187.90
  • Average True Range (ATR)
  • BCRX 0.51
  • CABO 14.80
  • MACD
  • BCRX 0.20
  • CABO -9.49
  • Stochastic Oscillator
  • BCRX 68.33
  • CABO 12.31

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About CABO Cable One Inc.

Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.

Share on Social Networks: